GSA Capital Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
57,057
+11,760
| +26% | +$270K | 0.09% | 301 |
|
|
2025
Q1 | $1.31M | Buy |
45,297
+27,863
| +160% | +$808K | 0.12% | 221 |
|
|
2024
Q4 | $647K | Buy |
17,434
+11,185
| +179% | +$415K | 0.05% | 712 |
|
|
2024
Q3 | $303K | Buy |
+6,249
| New | +$303K | 0.02% | 1208 |
|
|
2023
Q2 | – | Sell |
-21,852
| Closed | -$819K | – | 1488 |
|
|
2023
Q1 | $819K | Buy |
+21,852
| New | +$819K | 0.08% | 429 |
|
|
2021
Q2 | – | Sell |
-34,425
| Closed | -$631K | – | 1298 |
|
|
2021
Q1 | $631K | Buy |
+34,425
| New | +$631K | 0.1% | 243 |
|
|
2018
Q3 | – | Sell |
-33,000
| Closed | -$504K | – | 1613 |
|
|
2018
Q2 | $504K | Buy |
+33,000
| New | +$504K | 0.03% | 1149 |
|
|
2017
Q4 | – | Sell |
-22,400
| Closed | -$400K | – | 1539 |
|
|
2017
Q3 | $400K | Buy |
+22,400
| New | +$400K | 0.03% | 1094 |
|
|
2017
Q1 | – | Sell |
-56,544
| Closed | -$1.04M | – | 1726 |
|
|
2016
Q4 | $1.04M | Buy |
56,544
+38,444
| +212% | +$708K | 0.06% | 544 |
|
|
2016
Q3 | $343K | Buy |
+18,100
| New | +$343K | 0.02% | 1285 |
|
|
2016
Q1 | – | Sell |
-11,500
| Closed | -$164K | – | 1647 |
|
|
2015
Q4 | $164K | Sell |
11,500
-986
| -8% | -$14.1K | 0.01% | 1678 |
|
|
2015
Q3 | $146K | Buy |
+12,486
| New | +$146K | 0.01% | 1620 |
|
|
2015
Q2 | – | Sell |
-14,400
| Closed | -$215K | – | 1927 |
|
|
2015
Q1 | $215K | Sell |
14,400
-15,900
| -52% | -$237K | 0.01% | 1891 |
|
|
2014
Q4 | $352K | Buy |
+30,300
| New | +$352K | 0.02% | 1170 |
|